• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, October 20, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Researchers lengthen intervals between blood draws for warfarin patients

Bioengineer by Bioengineer
June 4, 2018
in Health
Reading Time: 1 min read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A new study finds stable patients on blood thinners may not need to get their blood drawn as often as they currently do. Researchers were able to increase the number of people waiting longer than five weeks in between their INR blood draws from less than half (41.8%) to more than two-thirds (69.3%).

"Warfarin patients with good INR control could have fewer blood draws, less discomfort and less cost," says Geoffrey Barnes, M.D., first author and cardiologist at the University of Michigan's Frankel Cardiovascular Center.

###

The U-M team published the new research in the Journal of Thrombosis and Haemostasis, thanks to participation in the Michigan Anticoagulation Quality Improvement Initiative (one of Blue Cross Blue Shield of Michigan's Collaborative Quality Initiatives). The paper studied 890 stable warfarin-treated patients in Michigan.

DOI: 10.1111/jth.14150

Media Contact

Haley Otman
[email protected]
734-764-2220
@umichmedicine

http://www.med.umich.edu

http://dx.doi.org/10.1111/jth.14150

Share12Tweet7Share2ShareShareShare1

Related Posts

Unraveling Apolipoprotein A-IV in Cardiac Amyloidosis

October 20, 2025

Digital Self-Service Platform Enhances Lung Cancer Screening Uptake

October 20, 2025

Parity and Lactation Trigger T Cell Breast Cancer Protection

October 20, 2025

Nurses’ Views on AI: Benefits, Challenges, Ethics

October 20, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1267 shares
    Share 506 Tweet 316
  • Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps

    300 shares
    Share 120 Tweet 75
  • New Study Suggests ALS and MS May Stem from Common Environmental Factor

    128 shares
    Share 51 Tweet 32
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    103 shares
    Share 41 Tweet 26

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Blood Test Advances Personalized Immunotherapy for Muscle-Invasive Bladder Cancer After Surgery

Unraveling Apolipoprotein A-IV in Cardiac Amyloidosis

Karel Svoboda and Jay Shendure Elected to National Academy of Medicine

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 65 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.